Corona Remedies IPO Creates Buzz as Grey-Market Premium Shoots Up to ₹365 Ahead of Subscription Opening on 8 December

The primary market is gearing up for an action-packed week as Corona Remedies prepares to launch its much-awaited initial public offering (IPO). Even before retail investors get a chance to apply, the pharma company has already become the talk of…






